BOARD OF DIRECTORS
The N2 Board of Directors consists of 10 individuals representing from across Canada.
Rachel Syme
Chair
Program Director, Research, Cystic Fibrosis Canada
Erin Cherban
Vice-Chair
Chief Clinical Research Officer for Advancing Health and the CIHR Canadian HIV Trials Network (CTN)
Muhammad Ali Hameed
Treasurer
Head of Operations, Population Health Research Institute
Jennifer Li
Secretary
Quality Manager, Cancer Clinical Research Unit, Princess Margaret Cancer Centre – University Health Network
Kathy Brodeur-Robb
Board Member
Executive Director C-17 Council
Patrick Clifford
N2 Board Member
Tammy Mah-Fraser
Board Member
Executive Director, Health Platforms, Alberta Innovates
Michelle Moldofsky
N2 Board Member
Founder, Moldofsky Professional Corporation
Jim Pankovich
N2 Board Member
Executive Vice President, Clinical Development, Bold Therapeutics Inc
Jordan Warford
N2 Board Member
Senior Director of Research for Nova Scotia Health